June 22, 2010

Drug maker Cephalon has started a partnership with the American Chronic Pain Association and the...

June 22, 2010

The Food and Drug Administration has approved a drug made by Genentech for treating a...

June 22, 2010

The Food and Drug Administration has granted orphan drug designation to an investigational treatment for...

June 21, 2010

The Food and Drug Administration has approved a new test for detecting HIV antigen and...

June 20, 2010

Drug maker Ferring Pharmaceuticals has launched a new treatment for women with cyclic heavy menstrual...

June 20, 2010

Swiss drug maker Roche has started a risk-mitigation plan in the late-stage clinical trial of...

June 17, 2010

The Food and Drug Administration has approved a drug as an early treatment for a...

June 16, 2010

An investigational drug for lupus that could become the first new treatment for the disease...

June 16, 2010

A division of German drug maker Merck KGaA has resumed its clinical trial of a...

June 16, 2010

Arthritis patients at risk of harmful gastrointestinal side effects due to use of a class...

June 15, 2010

Two drug makers will work together to develop a drug for the treatment of endometriosis,...

June 15, 2010

The acting chief medical officer for GlaxoSmithKline will lead a phase 3 trial for an...

June 15, 2010

An investigational drug for rheumatoid arthritis significantly reduced symptoms in patients, according to results of...

June 15, 2010

Drug maker OXiGENE has finished enrolling patients for a mid-stage clinical trial of a lung...

June 14, 2010

An investigational drug for treating multiple sclerosis has a shot at becoming a top seller,...

June 14, 2010

The Food and Drug Administration has agreed to speed up the review of a Genzyme...

June 14, 2010

Immunomedics has started a trial of an investigational drug for treating cancer of the plasma...

June 13, 2010

A drug made by Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals failed to extend overall survival...

June 13, 2010

An advisory committee of the Food and Drug Administration unanimously recommended approval for an investigational...

June 13, 2010

Teva Pharmaceutical Industries has invested $11.9 million in Andromeda Biotech, a company that develops diabetes...

June 10, 2010

Diplomat Specialty Pharmacy on Friday announced Diplomat president and CEO Phil Hagerman was named Ernst...

June 10, 2010

The Food and Drug Administration said Friday it was evaluating data from two clinical trials...

June 9, 2010

An investigational insulin made by MannKind works at least as well in patients with Type...

June 8, 2010

German drug maker Bayer HealthCare said a 16-year follow-up to a clinical trial of one...